SUMMARY Plasma viscosity has several advantages over the erythrocyte sedimentation rate as a measurement ofan acute phase response ofmore than 24 hours' duration. A new capillary viscometer (Coulter Viscometer II), which gives an automated measurement of plasma viscosity, was compared with the selected manual method (Harkness viscometer) of the International Committee for Standardization in Haematology. Automated measurement ofplasma viscosity at 25°C showed close correlation (r = 0-979, p < 0-002) with the selected method for 160 specimens of plasma. Satisfactory precision both within batch and between batch (coefficients of variation of 1-7% or less) was obtained at viscosity values up to 5 7 mPa-s. There was no detectable carry over between samples and viscosity values were corrected adequately for ambient temperature for the range 15-32°C. Careful daily cleaning was required to prevent accumulation of protein within the automatic sampling valve of the instrument. Automated measurement of plasma viscosity is an attractive alternative to measurement of the erythrocyte sedimentation rate.
Tissue damage induces a local inflammatory response that in turn stimulates, through interleukin 1 and other mediators, an increase in hepatic synthesis of several acute phase proteins.' Quantitative assay of these acute phase proteins in serum is useful for diagnosing and monitoring an inflammatory response.2 In the early stages ofinflammation (< 24 hours), assay ofthe fast responding C reactive protein is the test ofchoice, whereas the more complex hyperproteinaemia of the later stages of inflammation (> 24 hours) should be measured by tests such as the erythrocyte sedimentation rate (ESR) and plasma viscosity, which are sensitive to the combined effect of multiple proteins. 3 Measurement of plasma viscosity has several advantages over measurement of ESR.2' These include independence from the effects of anaemia, polycythaemia, and erythrocyte deformability; a reference range that is independent of sex and less dependent on age; a shorter assay time; the facility to store plasma for subsequent assay; and the potential for calibration, quality control, and automation. 
Patients and methods
Venous blood, anticoagulated with the dipotassium salt of ethylenediamine tetra-acetic acid (1 -5-2 0 mg/ ml) was collected from healthy controls, hospital patients with an acute phase or chronic phase inflammatory response, and patients with paraproteinaemia. Blood samples were centrifuged at 1500 g for 10 minutes within five hours of venepuncture, and the supernatant plasma was stored at room temperature in a capped plastic tube until assayed ( All viscosity measurements with the Viscometer II were corrected by the instrument to a selected temperature of 25°C to permit comparison with the Harkness viscometer, the water bath of which was maintained at 25°C. To check the instrument's ability to correct to 25°C, the Viscometer II was placed in a temperature controlled room at 1 5°C, 25°C, and then 32°C. Viscosity measurements were then made on 10 aliquots of the manufacturer's low control reagent, calibrator, and high control reagent. The mean results (table 2) show adequate correction of the viscosity readings at 15°C and 32°C to within 1-7% of the measured viscosity at 25°C. Cooke, Stuart Plasma samples from 160 hospital patients were assayed in parallel using a Viscometer II and a Harkness viscometer at 25°C and showed a close linear association (r = 0-979, gradient = 0-969, intercept = 0-058). The correlation for 50 of these patients, selected to cover the viscosity range 1 38 to 5-02 mPs-s, is shown in fig 1. Within batch precision was determined at four levels ofviscosity using plasma from four patients. The coefficients of variation for 10 aliquots from each specimen of plasma were 0 5% at 1 07 mPa-s (plasma diluted with 3 1% w/v trisodium citrate), 0-6% at 1-64 mPa-s, 1-3% at 3-78 mPa-s, and 1-7% at 5-66 mPa-s. Between batch precision was determined at three measurements of viscosity using the manufacturer's low control reagent, calibrator, and high control reagent. The coefficients of variation for 10 aliquots of each reagent were 0 53% at 1-20 mPa-s, 0 55% at 1 60 mPa's, and 0 58% at 2-00 mPa-s.
A specimen of normal plasma was diluted, using 3*1% w/v trisodium citrate to give a low viscosity would further reduce the biohazard. With this limitation, the Viscometer II offers a useful automated measurement of the large molecular weight plasma proteins that are present in the later stages of the inflammatory response. This measurement has the important advantage, compared with measuring erythrocyte sedimentation, of being independent of the effects of haematocrit. Because plasma viscosity can be measured within 15 minutes, including centrifugation time, results can be made available to outpatient clinics and, because plasma can be stored at room temperature provided it has been separated from the packed erythrocytes,4 specimens sent by post can be tested. Laboratory quality control procedures for measuring plasma viscosity are also much simpler than for measuring erythrocyte sedimentation.
The Viscometer II performed satisfactorily as an automated instrument but quality control programmes should incorporate a check for accumulation of protein within the sampling valve. Although the present study did not include determination of reference ranges, these are likely to be identical to those determined by the selected method of the International Committee for Standardization in Haematology (1.501-72 mPa.s at 25°C, and 1. 161-33 mPa-s at 37°C).' Although plasma viscosity is independent of sex and largely independent of age,'2 the lower plasma fibrinogen concentration of the newborn'3 and the higher plasma fibrinogen concentration of the elderly'4 indicate the need for further studies to determine more exact reference ranges at these extremes of age.
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